Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.94
At close: May 23 EDT
$2.99
0.051.70%
Pre-Market: 7:23 AM EDT
Comments
Loading...
Terns Pharma Analyst Ratings and Price Targets | NASDAQ:TERN | Benzinga
Terns Pharmaceuticals Inc has a consensus price target of $15.65 based on the ratings of 11 analysts. The high is $23 issued by Roth MKM on August 8, 2023. The low is $7.5 issued by HC Wainwright & Co. on December 4, 2024. The 3 most-recent analyst ratings were released by BMO Capital, JMP Securities, and JMP Securities on May 13, 2025, April 21, 2025, and December 4, 2024, respectively. With an average price target of $18.33 between BMO Capital, JMP Securities, and JMP Securities, there's an implied 513.15% upside for Terns Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
JMP Securities
Oppenheimer
HC Wainwright & Co.
UBS
1calculated from analyst ratings
Analyst Ratings for Terns Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 401.67% | BMO Capital | Etzer Darout44% | $26 → $15 | Maintains | Outperform | Get Alert |
| 04/21/2025 | Buy Now | 568.9% | JMP Securities | Silvan Tuerkcan47% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | — | William Blair | Andy Hsieh26% | — | Initiates | → Market Perform | Get Alert |
| 12/04/2024 | Buy Now | 568.9% | JMP Securities | Silvan Tuerkcan47% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/04/2024 | Buy Now | 568.9% | Oppenheimer | Jay Olson61% | $17 → $20 | Maintains | Outperform | Get Alert |
| 12/04/2024 | Buy Now | 150.84% | HC Wainwright & Co. | Ed Arce58% | $7.5 → $7.5 | Reiterates | Neutral → Neutral | Get Alert |
| 11/13/2024 | Buy Now | 150.84% | HC Wainwright & Co. | Ed Arce58% | $5.5 → $7.5 | Maintains | Neutral | Get Alert |
| 10/31/2024 | Buy Now | 468.56% | Oppenheimer | Jay Olson61% | → $17 | Initiates | → Outperform | Get Alert |
| 09/16/2024 | Buy Now | 769.57% | BMO Capital | Etzer Darout44% | $19 → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | Buy Now | 568.9% | JMP Securities | Silvan Tuerkcan47% | $15 → $20 | Maintains | Market Outperform | Get Alert |
| 09/03/2024 | Buy Now | 401.67% | JMP Securities | Silvan Tuerkcan47% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/06/2024 | Buy Now | 535.45% | BMO Capital | Etzer Darout44% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | Buy Now | 83.95% | HC Wainwright & Co. | Ed Arce58% | $5.5 → $5.5 | Reiterates | Neutral → Neutral | Get Alert |
| 04/30/2024 | Buy Now | 401.67% | JMP Securities | Silvan Tuerkcan47% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/30/2024 | Buy Now | 83.95% | HC Wainwright & Co. | Ed Arce58% | $5.5 → $5.5 | Reiterates | Neutral → Neutral | Get Alert |
| 03/27/2024 | Buy Now | 502.01% | UBS | Eliana Merle43% | $19 → $18 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | 401.67% | JMP Securities | Silvan Tuerkcan47% | $17 → $15 | Maintains | Outperform | Get Alert |
| 03/15/2024 | Buy Now | 83.95% | HC Wainwright & Co. | Ed Arce58% | $5.5 → $5.5 | Reiterates | Neutral → Neutral | Get Alert |
| 03/15/2024 | Buy Now | 535.45% | BMO Capital | Etzer Darout44% | $18 → $19 | Maintains | Outperform | Get Alert |
| 01/10/2024 | Buy Now | 83.95% | HC Wainwright & Co. | Ed Arce58% | $8 → $5.5 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/27/2023 | Buy Now | 234.45% | Mizuho | Graig Suvannavejh51% | $17 → $10 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 167.56% | HC Wainwright & Co. | Ed Arce58% | $11 → $8 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 267.89% | JP Morgan | Eric Joseph43% | $10 → $11 | Maintains | Neutral | Get Alert |
| 08/08/2023 | Buy Now | 669.23% | Roth MKM | Dylan Dupuis60% | → $23 | Reiterates | → Buy | Get Alert |
| 07/26/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/30/2023 | Buy Now | 669.23% | Roth MKM | Dylan Dupuis60% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/30/2023 | Buy Now | 435.12% | Mizuho | Graig Suvannavejh51% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2023 | Buy Now | 435.12% | Mizuho | Graig Suvannavejh51% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | Buy Now | 435.12% | Mizuho | Graig Suvannavejh51% | → $16 | Initiates | → Buy | Get Alert |
| 06/07/2023 | Buy Now | 502.01% | Jefferies | Akash Tewari41% | → $18 | Initiates | → Buy | Get Alert |
| 05/31/2023 | Buy Now | 669.23% | Roth MKM | Dylan Dupuis60% | → $23 | Initiates | → Buy | Get Alert |
| 05/19/2023 | Buy Now | 267.89% | HC Wainwright & Co. | Ed Arce58% | → $11 | Reiterates | Neutral → Neutral | Get Alert |
| 05/16/2023 | Buy Now | 234.45% | JP Morgan | Eric Joseph43% | $9 → $10 | Maintains | Neutral | Get Alert |
| 05/16/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | $17 → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/08/2023 | Buy Now | 502.01% | BMO Capital | Etzer Darout44% | → $18 | Initiates | → Outperform | Get Alert |
| 03/29/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | → $17 | Reiterates | → Market Outperform | Get Alert |
| 03/29/2023 | Buy Now | 201% | JP Morgan | Eric Joseph43% | $6 → $9 | Maintains | Neutral | Get Alert |
| 03/29/2023 | Buy Now | 267.89% | HC Wainwright & Co. | Ed Arce58% | $7 → $11 | Maintains | Neutral | Get Alert |
| 02/14/2023 | Buy Now | 468.56% | JMP Securities | Silvan Tuerkcan47% | → $17 | Initiates | → Market Outperform | Get Alert |
| 02/07/2023 | Buy Now | 535.45% | UBS | Eliana Merle43% | → $19 | Initiates | → Buy | Get Alert |
| 12/29/2022 | Buy Now | 134.11% | HC Wainwright & Co. | Ed Arce58% | $6 → $7 | Maintains | Neutral | Get Alert |
| 12/20/2022 | Buy Now | 368.23% | Goldman Sachs | Corinne Jenkins47% | $9 → $14 | Maintains | Buy | Get Alert |
| 09/28/2022 | Buy Now | 201% | Goldman Sachs | Corinne Jenkins47% | $4 → $9 | Maintains | Buy | Get Alert |
| 09/12/2022 | Buy Now | 100.67% | HC Wainwright & Co. | Ed Arce58% | → $6 | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Terns Pharma (TERN) stock?
The latest price target for Terns Pharma (NASDAQ:TERN) was reported by BMO Capital on May 13, 2025. The analyst firm set a price target for $15.00 expecting TERN to rise to within 12 months (a possible 401.67% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Terns Pharma (TERN)?
The latest analyst rating for Terns Pharma (NASDAQ:TERN) was provided by BMO Capital, and Terns Pharma maintained their outperform rating.
When was the last upgrade for Terns Pharma (TERN)?
There is no last upgrade for Terns Pharma
When was the last downgrade for Terns Pharma (TERN)?
There is no last downgrade for Terns Pharma.
When is the next analyst rating going to be posted or updated for Terns Pharma (TERN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Terns Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Terns Pharma was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating Terns Pharma (TERN) correct?
While ratings are subjective and will change, the latest Terns Pharma (TERN) rating was a maintained with a price target of $26.00 to $15.00. The current price Terns Pharma (TERN) is trading at is $2.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
